ASSET TRANSFER AGREEMENT BETWEEN MAVERICK THERAPEUTICS, INC. AND HARPOON THERAPEUTICS, INC. Dated as of December 30, 2016 CONFIDENTIALAsset Transfer Agreement • January 29th, 2019 • Harpoon Therapeutics, Inc. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledJanuary 29th, 2019 Company Industry Jurisdiction* = This schedule or exhibit has been omitted in accordance with Item 601(b)(2) of Regulation S-K. A copy of the omitted schedule and/or exhibit will be furnished to the Securities and Exchange Commission on request.
ASSET TRANSFER AGREEMENT BETWEEN MAVERICK THERAPEUTICS, INC. AND HARPOON THERAPEUTICS, INC. Dated as of December 30, 2016 CONFIDENTIALAsset Transfer Agreement • December 27th, 2018 • Harpoon Therapeutics, Inc. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledDecember 27th, 2018 Company Industry Jurisdiction* = This schedule or exhibit has been omitted in accordance with Item 601(b)(2) of Regulation S-K. A copy of the omitted schedule and/or exhibit will be furnished to the Securities and Exchange Commission on request.